• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Revolutions Medical Corporation Continues to Secure Its International Patent Rights

Posted on: Wednesday, 28 May 2008, 12:00 CDT

Revolutions Medical Corporation (OTCBB: RMCP) is filing for International patent protection in Mexico, Canada, China, Japan, and Europe for its additional RevVac Syringe patent. "It is very important to have foreign protection for our proprietary safety syringe technology as we move through the FDA 510K application process and into manufacturing," states Ron Wheet, CEO of Revolutions Medical Corporation. Richard Moseley, United States Patent Attorney said, "I have been writing syringe patents for more than twenty years and Revolutions Medical's proprietary vacuum technology patents are the most unique and advanced for the safety syringe market that I have ever read or worked on."

About Revolutions Medical Corporation

Revolutions Medical Corporation is committed to continually developing and distributing new products and tools to the medical industry, whether internally or through acquisitions. Its goals are to make health care safer and less expensive by reducing risks and cutting time and expenses. Its products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion.

Safe Harbor

Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.

Source: Business Wire

More News in this Category